AU3324000A - Use of niaouli essential oil as transdermal permeation enhancer - Google Patents
Use of niaouli essential oil as transdermal permeation enhancerInfo
- Publication number
- AU3324000A AU3324000A AU33240/00A AU3324000A AU3324000A AU 3324000 A AU3324000 A AU 3324000A AU 33240/00 A AU33240/00 A AU 33240/00A AU 3324000 A AU3324000 A AU 3324000A AU 3324000 A AU3324000 A AU 3324000A
- Authority
- AU
- Australia
- Prior art keywords
- essential oil
- permeation enhancer
- transdermal permeation
- niaouli essential
- niaouli
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITRM99A0151 | 1999-03-10 | ||
| IT1999RM000151A IT1305303B1 (en) | 1999-03-10 | 1999-03-10 | USE OF NIAOULI ESSENTIAL OIL AS A PROMOTER FOR TRANSDERMAL PERMEAZION. |
| PCT/IT2000/000079 WO2000053228A2 (en) | 1999-03-10 | 2000-03-09 | Use of niaouli essential oil as transdermal permeation enhancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3324000A true AU3324000A (en) | 2000-09-28 |
Family
ID=11406548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU33240/00A Abandoned AU3324000A (en) | 1999-03-10 | 2000-03-09 | Use of niaouli essential oil as transdermal permeation enhancer |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1159009A2 (en) |
| AU (1) | AU3324000A (en) |
| IT (1) | IT1305303B1 (en) |
| WO (1) | WO2000053228A2 (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| DE10032132A1 (en) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition |
| DE10053383A1 (en) * | 2000-10-27 | 2002-05-08 | Bionorica Arzneimittel Gmbh | Use of terpenes as enhancers of transmucosal absorption and pharmaceutical preparations containing terpenes |
| DE10056011A1 (en) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Well tolerated plaster for controlled delivery of essential oils to skin or air, has active agent containing matrix comprising polyisobutylene, amorphous poly-alpha-olefin and optionally filler |
| ITMI20041855A1 (en) * | 2004-09-29 | 2004-12-29 | Polichem Sa | PHARMACEUTICAL COMPOSITIONS OF ALFA-DIHYDROERGOCRIPTINE FOR TRANSDERMAL AND-OR TRANSMUCOUS USE. |
| MX2010013946A (en) * | 2008-06-24 | 2011-02-15 | Intervet Int Bv | PHARMACEUTICAL TRANSDERMIC COMPOSITIONS AND METHOD TO TREAT INFLAMMATION IN WON |
| MX2016016469A (en) | 2014-06-30 | 2017-04-10 | Koninklijke Philips Nv | Sample holder for biological samples. |
| US10232048B1 (en) * | 2014-11-18 | 2019-03-19 | Divine Api-Logics, LLC | Apitherapy method and composition |
| EP3723729B8 (en) * | 2017-12-11 | 2023-11-01 | Meat & Livestock Australia Limited | Transdermal analgesic formulation |
| PL443690A1 (en) * | 2023-02-05 | 2024-08-12 | Rodakowska Ewelina | Composition of plant-derived compounds, method of its preparation and use for medicinal purposes |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0609330A1 (en) * | 1991-10-26 | 1994-08-10 | FLOCKHART, Ian | Composition for topical application |
| DE19518836C2 (en) * | 1995-05-23 | 1997-05-22 | Gisela Hartwig | Medicines or medicines, in particular for the prevention and treatment of pressure ulcers |
| IT1297080B1 (en) * | 1997-11-26 | 1999-08-03 | Andrea Carnevali | COMPOSITION FOR THE TREATMENT OF BURNS, SOLAR erythema, ABRASIONS, SAGS AND SKIN IRRITATIONS |
-
1999
- 1999-03-10 IT IT1999RM000151A patent/IT1305303B1/en active
-
2000
- 2000-03-09 WO PCT/IT2000/000079 patent/WO2000053228A2/en not_active Ceased
- 2000-03-09 AU AU33240/00A patent/AU3324000A/en not_active Abandoned
- 2000-03-09 EP EP00911257A patent/EP1159009A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000053228A3 (en) | 2000-11-16 |
| IT1305303B1 (en) | 2001-05-04 |
| EP1159009A2 (en) | 2001-12-05 |
| WO2000053228A2 (en) | 2000-09-14 |
| ITRM990151A1 (en) | 2000-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU763356C (en) | Fused-ring compounds and use thereof as drugs | |
| AU7389300A (en) | Methods of administration of glycopyrrolate compositions | |
| AU1585601A (en) | Transdermal administration of huperzine | |
| AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
| AU7490200A (en) | New and improved formulation for paclitaxel | |
| AU2001264313A1 (en) | Pyrazolopyridine compounds and use thereof as drugs | |
| AU4137400A (en) | Heterocyclic derivatives useful as anticancer agents | |
| AU4343500A (en) | Use of azetidinone compounds | |
| AU4458700A (en) | Uses of phenylglycine derivatives | |
| AU5326100A (en) | Pharmaceutical compositions and methods for use | |
| AU1887401A (en) | Medicinal composition | |
| AU2220801A (en) | Tricyclic compounds and addition salts thereof | |
| AU3324000A (en) | Use of niaouli essential oil as transdermal permeation enhancer | |
| AU5460800A (en) | Pharmaceutical transdermal compositions | |
| AU3869399A (en) | Transdermal administration of fenoldopam | |
| AU1068101A (en) | Transdermal administration of reboxetine | |
| AU2001227084A1 (en) | N-arylhydrazide compounds and use thereof as drugs | |
| AU2982000A (en) | Preparation of 9-hydrocarbyl-9-phosphabicyclononanes | |
| AU2003207450A1 (en) | Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier | |
| AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
| AU4614100A (en) | Cyanobiphenyl derivatives | |
| AU2001294257A1 (en) | Method of purifying pravastatin or its pharmacologically acceptable salt | |
| AU4917000A (en) | Oligohydroxyl substituted benzofuran-3-yl and pyridofuranylurea derivatives as phosphodiesterase iv inhibitors | |
| AU1226001A (en) | Phospholipids of hydroxyeicosatetraenoic acid-like derivatives | |
| AU7711800A (en) | Novel uses of 2-bromopalmitate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |